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Abstract 
The imaging and subsequent accurate diagnosis of paediatric brain tumours presents a 
radiological challenge, with magnetic resonance imaging playing a key role in providing 
tumour specific imaging information. Diffusion weighted and perfusion imaging are 
commonly used to aid the non-invasive diagnosis of children’s brain tumours, but are 
usually evaluated by expert qualitative review. Quantitative studies are mainly single centre 
and single modality.  
The aim of this work was to combine multi-centre diffusion and perfusion imaging, with 
machine learning, to develop machine learning based classifiers to discriminate between 
three common paediatric tumour types.  
The results show that diffusion and perfusion weighted imaging of both the tumour and 
whole brain provide significant features which differ between tumour types, and that 
combining these features gives the optimal machine learning classifier with >80% predictive 
precision. This work represents a step forward to aid in the non-invasive diagnosis of 
paediatric brain tumours, using advanced clinical imaging. 
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 Introduction 
 
Brain tumours are the most common solid tumours in children, accounting for 
approximately 25% of all childhood cancers. Magnetic resonance imaging (MRI) is 
commonly performed for children suspected of having a brain tumour at presentation. 
Challenges are faced by paediatric radiologists to diagnose paediatric brain tumour type 
using MRI, especially in tumours which do not enhance with gadolinium contrast agent (a 
significant fraction in paediatric radiology)(Koob and Girard, 2014). Therefore, if a 
combination of imaging methods can be used to quantify tumour cellular microstructure 
and perfusion, it may be possible to discriminate between low and high grade, as well as key 
tumour subtypes such as Pilocytic Astrocytoma, Ependymoma, and Medulloblastoma. 
Magnetic resonance spectroscopic methods have been shown to be highly predictive in 
discriminating between tumour types, however this technique is challenging to acquire in 
regions of the brain with poor magnetic field homogeneity and small lesions(Faghihi et al., 
2017; Lin and Chung, 2014). Therefore, other more commonly used imaging-based 
methods, such as diffusion and perfusion imaging, may be favourable to discriminate 
between tumour types in the paediatric brain.  
 
Diffusion weighted imaging (DWI) and dynamic susceptibility contrast imaging (DSC) are two 
advanced magnetic resonance imaging (MRI) techniques available to understand tissue 
microstructure and perfusion on a cellular and tissue level(Goo and Ra, 2017; Shah et al., 
2016; Zhou et al., 2011). These techniques have been used extensively to understand the 
role of cellularity and microvascular perfusion, in both paediatric and adult brain 
tumours(Hales et al., 2019; Poussaint et al., 2016), with strong correlations with histology 
for the aforementioned. DWI utilises diffusion sensitising preparation gradients to remove 
signal from static water compartments in the brain, producing images weighted by the 
speed of water motion in a given voxel. With the assumption of Brownian motion, diffusion 
weighted images can be used to calculate an ‘apparent diffusion coefficient (ADC) map’, 
with each voxel value corresponding to the ADC in the voxel (mm2s-1)(Le Bihan, 2003).  
 
DSC is used to spatially image the dynamics of a gadolinium containing contrast agent, using 
fast imaging techniques such as echo-planar imaging (EPI) and (PRESTO). Data are processed 
using non-linear fitting techniques to extract uncorrected cerebral blood volume (UCBV), 
leakage coefficient (K2) and corrected cerebral blood volume (CCBV) maps. CBV maps can 
then be analysed to quantify the perfusion in a given region of the brain(Shiroishi et al., 
2015). DSC has shown to be useful in quantifying perfusion differences between low- and 
high-grade tumours, as well as in stroke(Boada et al., 2005; Saenger and Christenson, 2010; 
Sanak et al., 2009).  
 
Supervised machine learning utilises data features (for example mean ADC or mean CBV) 
and classes (for example ‘high and low grade’ or tumour types) and to train mathematical 
algorithms (commonly based on linear algebra) to automatically assign data sets to classes. 
The ability of a learning algorithm to discriminate between classes can be quantitatively 
determined using methods such as ‘cross-validation’(Erickson et al., 2017). Previous results 
have shown the ability of supervised methods to separate between tumour subtypes and 
high/low grade tumours using magnetic resonance spectroscopy, with 1.5T and 3T results 
showing 79% and 86% balanced accuracy rate (BAR), respectively  (Vicente et al., 2013; 
Zarinabad et al., 2018). 
 
Applications of supervised learning to oncological medical imaging have commonly utilised 
single measures of the tumour microenvironment (such as image texture, ADC, perfusion, or 
spectroscopy) to discriminate between tumour types(Fetit et al., 2018; Gill et al., 2014; 
Orphanidou-Vlachou et al., 2014, 2013; Zarinabad et al., 2017). However, in this study, we 
hypothesise that combining ADC and perfusion data from tumour Region of Interest (ROI) 
and the whole brain, provides an increased accuracy for discriminating between low- and 
high-grade tumours, as well as between tumour sub-types, in comparison to ROI or whole 
brain measures alone.  
  
Methods 
 
Patient recruitment 
49 participants with suspected brain tumours (medulloblastoma (N = 17), pilocytic 
astrocytoma (N = 22),  ependymoma (N = 10)) were recruited from 4 clinical sites in the 
United Kingdom (Ethics reference: 04/MRE0/41, Birmingham Children’s Hospital, Newcastle 
Royal Victoria Infirmary, Queen’s Medical Centre, Liverpool Alder Hey). Participants 
underwent MRI, discussed below, before invasive biopsy to confirm diagnosis. 
All Ependymoma and Medulloblastoma cases were considered high grade, and Pilocytic 
Astrocytoma as low grade.  
 
Magnetic resonance imaging  
The imaging protocol for all participants was performed either at 3 or 1.5T and included 
standard anatomical imaging (T1-weighted, T2-weighted, T2-FLAIR, T1-post contrast), as well 
as diffusion weighted and dynamic susceptibility contrast, covering the tumour volume 
(imaging sequence and cohort details found in supplementary Table 1). 
 
Image post-processing and analysis  
Apparent diffusion coefficient maps were calculated from diffusion weighted imaging, using 
a linear fit between the two b-value images. DSC time-course data were processed using a 
gamma-variate fit to form UCBV maps. A leakage correction was undertaken to produce 
CCBV and K2 maps(Shiroishi et al., 2015). The root mean squared error of the gamma 
variate fit was used to mask noise and masking any absolute CBV value greater than 3.0 mL 
100g-1 min-1. Brain masking, including removal of background and the skull, was performed 
during the fitting process. CBV maps were normalised to normal appearing white matter.  
T2- weighted, ADC, and T1-post contrast images were registered to the first DSC volume with 
SPM12 (UCL), and tumour regions of interest drawn on T2 weighted imaging.  
 
Image analysis, performed in Matlab (2018b, The Mathworks, MA), consisted of calculating 
the image mean, standard deviation, skewness, and kurtosis on a volume by volume basis 
for diffusion and perfusion imaging maps maps for regions of interest and the whole brain. 
Tumour volume (cm3) was calculated from the T2 ROI masks.  
 Statistical analysis  
Imaging features were tested for normality using a Shapiro-Wilk test in R (3.6.1) with 
subsequent ANOVA/Kruskal-Wallace and Tukey post-hoc tests performed to assess for 
differences in imaging features between low- and high-grade groups, and between tumour 
types. Receiver Operator Curves (ROC) were defined from significant imaging components 
for comparison of low versus high-grade tumours, and the area under the curve (AUC) 
calculated. Statistical significance was determined at p < 0.05, with Bonferroni correction for 
multiple comparisons.  
 
Machine learning  
 
The discriminant ability of classifiers, described below, was assessed using the F-statistic (a 
measure of sensitivity and specificity of the learner) and the between group average 
precision (the average precision of the learner to correctly classify tumour types), after 
stratified 3-fold cross validation. Individual tumour group accuracy and F-statistics were also 
calculated. A flowchart demonstrating the processing pipeline is found in Figure 1.  
 
Tumour volume, ADC and DSC region of interest and whole brain features were processed 
using principal component analysis to reduce dimensionality, aiming for 95% data variance 
or N-1 components where not possible (where N is the size of the smallest group). 
Supervised machine learning was performed using the Orange toolbox (Orange) in Python 
(3.6), using a Neural Network, AdaBoost, random forest, a support vector machine, and k 
nearest-neighbours.  
Learning algorithms were initialised to first discriminate between low- and high-grade 
groups, and then between tumour sub-types. The Balanced Accuracy Rate (BAR), F-statistic, 
and individual group accuracies were calculated for each learner after stratified cross-
validation. 
A further approach to dimensionality reduction was undertaken by independently 
performing univariate statistical analysis (described above in ‘statistical analysis’ section) on 
3 stratified subsets of the imaging data (75:25% training:test set size). Features with the 
highest AUC over all subsets were selected for learning. This combination of features is 
termed here as the ‘univariate’ classifier. 
 
Data oversampling  
Two oversampling methods: data replication and SMOTE (Chawla et al., 2002; Zarinabad et 
al., 2018), were used to increase the ependymoma group size of training sets by 100%. The 
oversampled data was processed, with supervised learning, as above and results compared 
with no oversampling.   
Results 
 
Example DSC and DWI imaging is shown in Figure 2: T2-weighted (A), ADC(B), Uncorrected 
CBV (C), K2 (D), and Corrected CBV (E). 
 
Tumour Region of interest and whole brain analysis reveals features which differ between 
low- and high-grade tumours and some tumour types 
 
Region of interest and whole brain features analysis revealed a number of imaging features 
that were significantly different between low- and high-grade tumours. With ADC mean 
having the highest AUC of 0.8, with a range of 0.37 to 0.78 AUC for other features.  
 
Further to distinguishing between low- and high-grade tumours, significant differences in 
ADC features were observed between Pilocytic Astrocytomas and Medulloblastomas: ADC 
ROI mean (1.5 ± 0.3 vs 0.9 ± 0.2 mm2 s-1, p < 0.001, ACU = 0.75), ADC ROI skewness (0.9 ± 
1.0 vs 1.9 ± 0.9, p = 0.006),  and ADC ROI kurtosis (5 ± 3 vs 9 ± 5, p = 0.045, ACU = 0.65). A 
significant difference in tumour volume between Pilocytic Astrocytomas and Ependymomas 
was observed (2.3 ± 3.1 vs 9.0 ± 11.2 cm3, respectively, p = 0.02, AUC = 0.67).  
 
Whole brain analysis revealed a significant difference between high and low grade tumours; 
ADC mean (0.68 ± 0.24 vs 0.9 ± 0.2 mm2 s-1, p = 0.001, AUC = 0.77), and uncorrected CBV 
whole brain mean (0.11 ± 0.03 vs 0.13 ± 0.02 mL 100g-1 min-1, p = 0.002, AUC = 0.62). 
Pilocytic Astrocytomas and Medulloblastomas also differed in the whole brain features such 
as corrected CBV mean (1.1 ± 0.3 vs 1.2 ± 0.2 mL 100g-1 min-1, respectively, p = 0.009, AUC = 
0.62 and  ADC mean (0.9 ± 0.2 vs 0.7 ± 0.3 mm2 s-1, respectively, p < 0.001, AUC = 0.78). Full 
tumour subtype results are shown in Table 1. 
  
Supervised learning can distinguish between low- and high-grade tumours and different 
tumour types with a combination of region of interest and whole brain features.  
 
To discriminate between tumour types, the univariate classifier performed the best 
(features: ADC ROI mean, ADC whole brain kurtosis, uncorrected CBV ROI skewness, and 
tumour volume) using an AdaBoost learner (precision = 86%, F-statistic = 0.85). Excluding 
ADC whole brain kurtosis from the above classifier resulted in a reduction to 82% precision 
F-statistic = 0.75.  
Utilising PCA to reduce dimensionality did not perform as well as the univariate classifier, 
with BAR ranging from 66%-64% (all imaging features and all ROI features, respectively). All 
results including individual class precision are detailed in Tables 2A and B. 
 
A combination of all ROI features had the highest precision to discriminate between high- 
and low-grade tumours with a support vector machine (86% precision, 11 principal 
components). All other results for high-low grade classification are shown in supplementary 
table 3.  
 
Oversampling increases learner accuracy for some classifiers 
Oversampling increased classifier precision for PCA based classifiers, as demonstrated by 
large increase in BAR, results shown in Table 3A, however, it did not increase BAR for the 
univariate classifier (85% vs 85% vs 86%, no oversampling vs data replication vs SMOTE, 
respectively). Indeed, using oversampling methods with the univariate classifier showed an 
increase in the classification accuracy for Ependymomas, but little change for 
medulloblatomas and a decreased accuracy for pilocytic astrocytomas. All group precision 
and F-statistic results are presented in Table 3B. 
  
Discussion 
 
This study has demonstrated that a combination of multiparametric MRI, univariate 
analysis, and machine learning techniques can be employed to distinguish between both 
high- and low-grade paediatric brain tumours, as well as enabling tumour type classification 
with high accuracy (achieving 86% BAR).   
Previous studies have commonly focused on the use of a single data type (for example ADC 
or DSC perfusion measures) to discriminate between high- and low-grade tumour types as 
well as common tumour histological diagnoses, with results in this study agreeing with 
previous findings(Bull et al., 2012).  
Studies of diagnostic classifiers for tumours based on imaging have concentrated on using 
data from regions of interest drawn around the tumour or regions of abnormality on the 
conventional MRI. Here we have also investigated imaging features selected from the whole 
brain and shown that these are significantly different between the tumours. In addition we 
found that these features can improve the accuracy of the diagnostic classifier when 
included in it.  
 
A particularly interesting result of this study showed that feature selection, informed by 
univariate statistics, provided a classifier that outperformed other methods. This 
emphasises the importance of optimising the way in which features are selected for input to 
the machine learning classifier. Large numbers of features cannot be used due to the risk of 
over-fitting and, consequently, obtaining over optimistic estimates of the accuracy of the 
classifier. However, methods, such as principal component analysis, which select features by 
how much variability exists in the data, may not select the most discriminatory features but 
those that vary most throughout the data set used in this study.  
 
Previous MR spectroscopic studies at 1.5 and 3T utilising supervised machine learning have 
achieved similar results as demonstrated here(Vicente et al., 2013; Zarinabad et al., 2017)  
and it would be interesting to determine the added value of combining these modalities.  
Challenges are faced in the acquisition of DSC data, particularly the injection of gadolinium 
in a highly regulated manner in children and the use of arterial spin labelling. These may 
present an alternative option for utilising perfusion imaging in the future(Novak et al., 2019; 
Radbruch et al., 2015). 
 
Challenges are faced in paediatric oncological studies with low recruitment rates, due to the 
low disease incidence in the population. Therefore, multi-centre approaches present an 
opportunity to both collect the data sets required to undertake machine learning 
approaches, as well as increasing the statistical power of the study itself. Here we have also 
shown that multi-parametric data from multiple centres can be combined to form powerful 
classifiers in the study of paediatric brain tumours.  
 
Work beyond this study could focus on the expansion to other less common brain tumour 
sub-types, such as such as genetic subtypes of Medulloblastomas, to extend the relevance 
and scope of this work. This, in turn, will aid in the radiological classification and diagnosis of 
many other tumour types beyond the main three represented in this study. Furthermore, 
the addition of other microstructure data, such as diffusion kurtosis and intra-voxel 
incoherent motion, may provide further information regarding the tumour 
microenvironment, and, therefore, further aid in the discrimination between tumour types. 
 
Limitations of this study include low participant numbers in the Ependymoma group, a 
common challenge in paediatric imaging studies. This was mitigated, to some extent, by the 
use of oversampling in the machine learning classifiers, although further numbers in this 
group should be obtained. Overall, classifier results have shown the power of machine 
learning to distinguish between tumour types.  
 
In conclusion, this study has demonstrated the power of combining advanced MRI methods 
with machine learning to provide a non-invasive diagnosis of paediatric tumour types.  
 
 
 
 
 
 
Figure captions  
 
Figure 1 – Data processing pipeline used in this study.  
 
 
Figure 2 – Example anatomical, perfusion and diffusion maps of an Ependymoma.  A) T2-
weighted imaging, B) Apparent Diffusion Coefficient map, C) Uncorrected Cerebral Blood 
Volume map, D) K2 map, E) Corrected Cerebral Blood Volume map. 
 
 
Table 1 – Univariate tumour separation results. A number of imaging features were found 
to be significant (* = Pilocytic Astrocytoma vs Medulloblastoma at p < 0.05, ** = Pilocytic 
Astrocytoma vs Ependymoma at p < 0.05).  
 
 
Table 2 - Supervised learning results for tumour type discrimination.  
 
 
Table 3 – Results containing standard, random, and SMOTE oversampling of ependymoma 
features. Balanced accuracy rate for all, ROI, whole brain, and optimized features shown in 
A, and group classification results from best performing classifier in B (precision (%), F-
statistic).  
 
 
Supplementary table 1 – Cohort (A) and imaging parameters (B) used in this study. 
 
 
Supplementary Table 2 – Significant univariate results from high/low grade separation. 
Analysis showed a number of significant ADC and DSC imaging features between low and 
high grade groups. AUC = Area under the curve. 
 
Supplementary table 3 – Supervised learning results for low/high grade. Results showed 
that a PCA reduced combination of ROI features combined with a Support Vector Machine 
provided the best learner to discriminate between high and low grade tumours.  
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